Effect of lycopene on prostate LNCaP cancer cells in culture

Journal of Medicinal Food

Volumn 5, Issue 4, 2002, Pages 181-187

  Kim, Linda ^a   Rao, A Venket ^a,b   Rao, Leticia G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LYCOPENE;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RISK; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DIET; DILUTION; EPIDEMIOLOGICAL DATA; FOLLOW UP; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

BOVINAE;

EID: 0036938115     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662002763003320     Document Type: Article

References (33)

1. Dhom G: Epidemiological aspects of latent and clinically manifest carcinoma of the Prostate. J Cancer Res Clin Oncol 1983;106:210-218.
2. Parker SL, Tong T, Bolden BA, Wingo PA: Cancer statistics 1998. CA Cancer J Clin 1998;46:5-27.
3. Ames BN, Gold LS, Willet WC: Causes and prevention of cancer. Proc Natl Acad Sci USA 1995;92: 5258-5265.
4. Pincemail J: Free radicals and antioxidants in human disease. In: Analysis of Free Radicals in Biological Systems (Favier AE, Cadet J, Kalyanaraman B, Fontecave M, Pierre J-L, eds.). Birkhauser Verlag, Basel, 1995, pp. 83-98.
5. Ames BN, Shigenaga MK, Hagan TM: Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993;90:7915-7922.
6. Halliwell B, Murcia MA, Chirico S, Aruoma OI: Free radicals and antioxidants in food and in vivo: What they do and how they work. Crit Rev Food Sci Nutr 1995;35:7-20.
7. Halliwell B: Free radicals, antioxidants and human disease: Curiosity, cause or consequence? Lancet 1994;344:721-724.
8. Witzum JL: The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-795.
9. Das S: Vitamin E in the genesis and prevention of cancer. Acta Oncol 1994;33:615-623.
10. El Attar TM, Lin HS: Vitamin E succinate potentiates the inhibitory effect of prostaglandins on oral squamous carcinoma cell proliferation. Prostaglandins Leukot Essent Fatty Acids 1995;52:69-73.
11. Schonberg S, Krokan HE: The inhibitory effects of conjugated dienoic derivatives of linoleic acid on the growth of human tumor cell lines is in part due to increased lipid peroxidation. Anticancer Res 1995;15: 1241-1246.
12. Vasavi H, Thangaraju M, Sachdanandam P: Effects of alpha-tocopherol on lipid peroxidation and antioxidant system in fibrosarcoma bearing rats. Mol Cell Biochem 1994;131:25-129.
13. Hunter DJ, Morris JS, Stampfer MJ, et al.: A prospective study of selenium status and breast cancer risk. JAMA 1990;264:1128-1131.
14. Van den Brandt PA, Goldbohn RA, Bode P, et al.: A prospective study on toenail selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst 1993;85: 224-229.
15. Van den Brandt PA, Goldbohn RA, Bode P, et al.: A prospective study on selenium status and the risk of lung cancer. Cancer Res 1993;53:4860-4865.
16. Helzlsouer KJ, Comstock GW, Morris JS, et al.: Selenium, lycopene, α-tocopherol, β-carotene, retinol and subsequent bladder cancer. Cancer Res 1989;49: 6144-6148.
17. Yoshizawa K, Willett WC, Morris JS, et al.: Study of prediagnostic selenium level in toe nails and the risk of advanced prostate cancer. J Natl Cancer Inst 1989; 90:1219-1224.
18. Rock CL: Carotenoids: Biology and treatment. Pharmacol Ther 1997;75:185-197.
19. Green JE, Greenberg NM, Ashendel CL, et al.: Workgroup 3: Transgenic and reconstitution models of prostate cancer. Prostate 1998;36:59-63.
20. Stahl W, Nicolai S, Briviba K, et al.: Biological activities of natural and synthetic carotenoids: Induction of gap junctional communication and singlet oxygen quenching. Carcinogenesis 1997;18:89-92.
21. Di Mascio P, Kaiser S, Sies H: Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274:532-538.
22. Stahl W, Schwarz W, Sundquist AR, Sies H: Cis-trans isomers of lycopene and β-carotene in human serum and tissues. Arch Biochem Biophys 1992;294:173-177.
23. Kaplan LA, Lau JM, Stein EA: Carotenoids: Composition, concentrations and relationships in various human organs. Clin Physiol Biochem 1990;8:1-10.
24. Clinton SK, Emenhiser C, Schwartz SJ, et al.: Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996; 5:823-833.
25. Hsing AW, Comstock GW, Abbey H, Polk B: Serologic precursors of cancer: Retinol, carotenoids and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-946.
26. Giovannucci E, Ascherio A, Rimm EB, et al.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-1776.
27. Levy J, Bosin E, Feldman B, et al.: Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 1995;24:257-266.
28. Gann PH, Ma J, Giovannucci E, et al.: Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999; 59:1225-1230.
29. Schmitz HH, Poor CL, Wellman RB, Erdman JW Jr: Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J Nutr 1991; 121:1613-1621.
30. Conklin KA: Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 2000;37:1-18.
31. Zhang LX, Cooney RV, Bertram JS: Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: Relationship to their cancer chemopreventive action. Carcinogenesis 1991;12:2109-2114.
32. Pastori M, Pfander H, Boscoboinik D, Azzi A: Lycopene in association with α-tocopherol at physiological concentrations inhibits proliferation of prostate carcinoma cells. Biochem Biophys Res Commun 1998;250:582-585.
33. Xu X, Wang Y, Constantinou AI, et al.: Solubilization and stabilization of carotenoids using micelles: Delivery of lycopene to cells in culture. Lipids 1999;34: 1031-1036.